Key result
Slow pathway modification for AVNRT in children achieved 100% acute success with rare recurrences and a 0.5% major complication rate, demonstrating safety and efficacy regardless of age.
Why the study?
Does slow pathway modification for AVNRT have similar efficacy and safety in young children (<10 years) compared to older children and adolescents?
Cohort (n=272)
Does slow pathway modification for AVNRT have similar efficacy and safety in young children (<10 years) compared to older children and adolescents?
Absolute Event Rate: 100% vs 100%
Slow pathway modification for AVNRT is highly successful and safe in young children (<10 years), with outcomes comparable to older pediatric patients.
No takes yet. Share an insight, caveat, or question.
Supports consideration of slow pathway modification for AVNRT in young children; leaves open need for randomized confirmation of durability.
Reddy et al. (2015) conducted a cohort in Atrioventricular nodal reentrant tachycardia (AVNRT) (n=272). Slow pathway modification (ablation) vs. Compared between young (<10 years) and older (≥10 years) patients was evaluated on Acute ablation success. Slow pathway modification for AVNRT in children achieved 100% acute success with rare recurrences and a 0.5% major complication rate, demonstrating safety and efficacy regardless of age.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: